Applied Dna Sciences Inc (NASDAQ: APDN) on Monday, soared 18.44% from the previous trading day, before settling in for the closing price of $1.79. Within the past 52 weeks, APDN’s price has moved between $1.67 and $506.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 60.75% annually for the last half of the decade. The company achieved an average annual earnings per share of 73.63%. With a float of $1.03 million, this company’s outstanding shares have now reached $1.08 million.
In an organization with 48 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 34.35%, operating margin of -353.23%, and the pretax margin is -230.85%.
Applied Dna Sciences Inc (APDN) Insider and Institutional Ownership
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Applied Dna Sciences Inc is 6.82%, while institutional ownership is 39.58%.
Applied Dna Sciences Inc (APDN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.63% per share during the next fiscal year.
Applied Dna Sciences Inc (NASDAQ: APDN) Trading Performance Indicators
Applied Dna Sciences Inc (APDN) is currently performing well based on its current performance indicators. A quick ratio of 4.53 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -285.87, a number that is poised to hit -3.00 in the next quarter and is forecasted to reach -5.50 in one year’s time.
Technical Analysis of Applied Dna Sciences Inc (APDN)
Let’s dig in a bit further. During the last 5-days, its volume was 6.65 million. That was better than the volume of 0.71 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 6.68%. Additionally, its Average True Range was 0.68.
During the past 100 days, Applied Dna Sciences Inc’s (APDN) raw stochastic average was set at 3.09%, which indicates a significant decrease from 7.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 372.30% in the past 14 days, which was higher than the 203.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.2300, while its 200-day Moving Average is $22.8600. However, in the short run, Applied Dna Sciences Inc’s stock first resistance to watch stands at $2.4100. Second resistance stands at $2.6900. The third major resistance level sits at $3.0000. If the price goes on to break the first support level at $1.8200, it is likely to go to the next support level at $1.5100. The third support level lies at $1.2300 if the price breaches the second support level.
Applied Dna Sciences Inc (NASDAQ: APDN) Key Stats
Market capitalization of the company is 2.35 million based on 1,104K outstanding shares. Right now, sales total 3,430 K and income totals -6,990 K. The company made 1,200 K in profit during its latest quarter, and -2,640 K in sales during its previous quarter.
